HGH Fragment 176-191 Peptide 5mg

HGH Fragment 176-191 Peptide 5mg: Product Overview

HGH Fragment 176-191 Peptide 5mg is a synthetic peptide derived from the C-terminal region of human growth hormone (hGH). This specialized growth hormone fragment has attracted scientific interest for its role in experimental studies of lipid metabolism, adipocyte signaling, and growth hormone-derived peptide activity.

Unlike full-length recombinant human growth hormone, HGH Fragment 176-191 contains only a short segment of the original hormone molecule. The 5mg designation identifies the stated quantity of peptide material in this product listing.

HGH Fragment 176-191 5mg Product Specifications

• Product Name: HGH Fragment 176-191 Peptide
• Alternative Names: HGH Frag 176-191, hGH Fragment 176-191
• Peptide Type: Synthetic growth hormone fragment
• Peptide Family: Human growth hormone-derived peptides
• Listed Quantity: 5mg
• Structure: 16 amino acid residues
• Research Category: Lipid metabolism and peptide signaling
• Product Category: Research Peptides

What Is HGH Fragment 176-191?

HGH Fragment 176-191 is a peptide corresponding to the final 16 amino acids of the human growth hormone sequence. Researchers have investigated peptides from this region to better understand the relationship between growth hormone structure and lipid-related biological processes.

The C-terminal region of human growth hormone has been studied in experimental models involving fat-cell metabolism and related signaling mechanisms. These investigations helped establish interest in shorter growth hormone-derived peptides.

HGH Fragment 176-191 is chemically distinct from full-length HGH and should not be treated as an equivalent replacement for recombinant human growth hormone.

Key Characteristics of HGH Fragment 176-191

• Growth Hormone-Derived Structure: Contains a defined segment from the C-terminal region of human growth hormone.
• Lipid Metabolism Research: Associated with experimental investigations involving fat-cell signaling and lipid metabolism.
• Distinct Molecular Identity: Structurally different from full-length HGH and related modified peptide analogs.
• Peptide Research Applications: Relevant to laboratory studies examining structure-function relationships and peptide-mediated biological processes.
• 5mg Presentation: Clearly identified peptide quantity for research documentation and product cataloging.

HGH Fragment 176-191 Mechanism of Action

Scientific research involving C-terminal growth hormone fragments has explored their possible influence on lipid metabolism and fat-cell activity.

Experimental studies of related modified fragments, including AOD-9604, have examined mechanisms associated with lipolysis and lipid storage. However, findings involving modified analogs cannot automatically be attributed to the unmodified HGH Fragment 176-191 peptide.

The mechanisms and clinical significance of these peptide interactions remain subjects of scientific investigation.

HGH Fragment 176-191 vs Human Growth Hormone (HGH)

Although both compounds are related to the human growth hormone molecule, HGH Fragment 176-191 and full-length HGH differ substantially in structure and biological activity.

• HGH Fragment 176-191: A short peptide sequence investigated in research involving lipid-related biological pathways.
• Human Growth Hormone: A complete 191-amino-acid protein hormone with established endocrine functions.
• Key Difference: A peptide fragment does not reproduce the complete molecular structure or biological activity of the original hormone.

HGH Fragment 176-191 vs AOD-9604

HGH Fragment 176-191 and AOD-9604 are closely related peptides frequently discussed together in growth hormone fragment research.

The native HGH 176-191 sequence begins with phenylalanine, whereas AOD-9604 is a modified analog containing an N-terminal tyrosine substitution. This structural distinction is important when interpreting scientific studies and verifying peptide identity.

Because commercial naming conventions may vary, the exact amino acid sequence should be confirmed through product-specific documentation.

HGH Fragment 176-191 Research Background

Research on human growth hormone fragments has investigated whether selected regions of the hormone participate in metabolic processes independently of the complete growth hormone molecule.

Preclinical investigations involving related C-terminal peptides have examined lipid oxidation, adipose tissue responses, and metabolic signaling in experimental models.

Clinical evidence for native HGH Fragment 176-191 remains limited. Research involving AOD-9604 has not established consistent clinically meaningful weight-loss benefits in humans. Results should therefore be interpreted according to the precise compound studied.

HGH Fragment 176-191 5mg Product Documentation

HGH Fragment 176-191 Peptide 5mg is identified by its stated peptide quantity and product name. Before evaluating the product, review the original packaging, label information, and available batch-specific analytical documentation.

Important product details include peptide identity, amino acid sequence, declared quantity, chemical form, and formulation-specific handling requirements.

Research findings do not establish the safety or effectiveness of HGH Fragment 176-191 for human treatment or weight management.